IDEXX Laboratories Debt to Equity Ratio 2011-2025 | IDXX
Current and historical debt to equity ratio values for IDEXX Laboratories (IDXX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. IDEXX Laboratories debt/equity for the three months ending June 30, 2025 was 0.24.
| IDEXX Laboratories Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-06-30 | $1.87B | $1.46B | 1.28 |
| 2025-03-31 | $1.77B | $1.45B | 1.22 |
| 2024-12-31 | $1.70B | $1.60B | 1.06 |
| 2024-09-30 | $1.73B | $1.62B | 1.07 |
| 2024-06-30 | $1.84B | $1.58B | 1.16 |
| 2024-03-31 | $1.79B | $1.57B | 1.14 |
| 2023-12-31 | $1.78B | $1.49B | 1.20 |
| 2023-09-30 | $1.79B | $1.30B | 1.38 |
| 2023-06-30 | $1.78B | $1.09B | 1.62 |
| 2023-03-31 | $1.97B | $0.84B | 2.34 |
| 2022-12-31 | $2.14B | $0.61B | 3.51 |
| 2022-09-30 | $2.16B | $0.48B | 4.55 |
| 2022-06-30 | $2.15B | $0.46B | 4.71 |
| 2022-03-31 | $1.95B | $0.64B | 3.05 |
| 2021-12-31 | $1.75B | $0.69B | 2.53 |
| 2021-09-30 | $1.63B | $0.76B | 2.16 |
| 2021-06-30 | $1.66B | $0.75B | 2.22 |
| 2021-03-31 | $1.62B | $0.70B | 2.31 |
| 2020-12-31 | $1.66B | $0.63B | 2.63 |
| 2020-09-30 | $1.61B | $0.44B | 3.64 |
| 2020-06-30 | $1.69B | $0.27B | 6.17 |
| 2020-03-31 | $1.78B | $0.11B | 16.46 |
| 2019-12-31 | $1.66B | $0.18B | 9.31 |
| 2019-09-30 | $1.55B | $0.20B | 7.64 |
| 2019-06-30 | $1.55B | $0.17B | 9.05 |
| 2019-03-31 | $1.63B | $0.05B | 31.41 |
| 2018-12-31 | $1.55B | $-0.01B | -167.51 |
| 2018-09-30 | $1.55B | $0.00B | -1134.18 |
| 2018-06-30 | $1.56B | $-0.04B | -38.23 |
| 2018-03-31 | $1.52B | $-0.05B | -31.00 |
| 2017-12-31 | $1.77B | $-0.05B | -32.82 |
| 2017-09-30 | $1.72B | $-0.05B | -35.50 |
| 2017-06-30 | $1.72B | $-0.09B | -20.01 |
| 2017-03-31 | $1.65B | $-0.07B | -22.27 |
| 2016-12-31 | $1.64B | $-0.11B | -15.15 |
| 2016-09-30 | $1.45B | $0.06B | 26.29 |
| 2016-06-30 | $1.50B | $-0.01B | -176.25 |
| 2016-03-31 | $1.55B | $-0.07B | -21.04 |
| 2015-12-31 | $1.56B | $-0.08B | -18.56 |
| 2015-09-30 | $1.52B | $-0.04B | -39.07 |
| 2015-06-30 | $1.47B | $0.01B | 171.77 |
| 2015-03-31 | $1.40B | $0.03B | 40.99 |
| 2014-12-31 | $1.27B | $0.12B | 10.77 |
| 2014-09-30 | $1.06B | $0.23B | 4.62 |
| 2014-06-30 | $0.83B | $0.45B | 1.83 |
| 2014-03-31 | $0.75B | $0.51B | 1.46 |
| 2013-12-31 | $0.71B | $0.52B | 1.38 |
| 2013-09-30 | $0.66B | $0.54B | 1.24 |
| 2013-06-30 | $0.61B | $0.55B | 1.12 |
| 2013-03-31 | $0.50B | $0.63B | 0.79 |
| 2012-12-31 | $0.47B | $0.64B | 0.74 |
| 2012-09-30 | $0.48B | $0.62B | 0.77 |
| 2012-06-30 | $0.48B | $0.59B | 0.81 |
| 2012-03-31 | $0.49B | $0.57B | 0.87 |
| 2011-12-31 | $0.49B | $0.54B | 0.91 |
| 2011-09-30 | $0.38B | $0.59B | 0.65 |
| 2011-06-30 | $0.34B | $0.61B | 0.56 |
| 2011-03-31 | $0.31B | $0.60B | 0.52 |
| 2010-12-31 | $0.32B | $0.57B | 0.56 |
| 2010-09-30 | $0.32B | $0.55B | 0.58 |
| 2010-06-30 | $0.31B | $0.52B | 0.59 |
| 2010-03-31 | $0.33B | $0.50B | 0.66 |
| 2009-12-31 | $0.29B | $0.52B | 0.57 |
| 2009-09-30 | $0.32B | $0.50B | 0.63 |
| 2009-06-30 | $0.33B | $0.47B | 0.70 |
| 2009-03-31 | $0.33B | $0.45B | 0.73 |
| 2008-12-31 | $0.33B | $0.44B | 0.75 |
| 2008-09-30 | $0.34B | $0.44B | 0.78 |
| 2008-06-30 | $0.34B | $0.43B | 0.79 |
| 2008-03-31 | $0.30B | $0.43B | 0.70 |
| 2007-12-31 | $0.26B | $0.44B | 0.60 |
| 2007-09-30 | $0.25B | $0.42B | 0.61 |
| 2007-06-30 | $0.26B | $0.39B | 0.68 |
| 2007-03-31 | $0.23B | $0.41B | 0.57 |
| 2006-12-31 | $0.15B | $0.41B | 0.37 |
| 2006-09-30 | $0.14B | $0.39B | 0.35 |
| 2006-06-30 | $0.14B | $0.36B | 0.40 |
| 2006-03-31 | $0.11B | $0.36B | 0.31 |
| 2005-12-31 | $0.12B | $0.37B | 0.33 |
| 2005-09-30 | $0.11B | $0.38B | 0.29 |
| 2005-06-30 | $0.11B | $0.39B | 0.28 |
| 2005-03-31 | $0.10B | $0.39B | 0.26 |
| 2004-12-31 | $0.12B | $0.40B | 0.29 |
| 2004-09-30 | $0.10B | $0.41B | 0.25 |
| 2004-06-30 | $0.10B | $0.42B | 0.23 |
| 2004-03-31 | $0.10B | $0.43B | 0.23 |
| 2003-12-31 | $0.11B | $0.41B | 0.26 |
| 2003-09-30 | $0.09B | $0.40B | 0.23 |
| 2003-06-30 | $0.09B | $0.37B | 0.25 |
| 2003-03-31 | $0.08B | $0.35B | 0.24 |
| 2002-12-31 | $0.08B | $0.34B | 0.22 |
| 2002-09-30 | $0.09B | $0.32B | 0.29 |
| 2002-06-30 | $0.07B | $0.31B | 0.23 |
| 2002-03-31 | $0.08B | $0.31B | 0.26 |
| 2001-12-31 | $0.07B | $0.30B | 0.24 |
| 2001-09-30 | $0.07B | $0.29B | 0.26 |
| 2001-06-30 | $0.07B | $0.28B | 0.24 |
| 2001-03-31 | $0.07B | $0.26B | 0.25 |
| 2000-12-31 | $0.07B | $0.26B | 0.28 |
| 2000-09-30 | $0.09B | $0.27B | 0.33 |
| 2000-06-30 | $0.09B | $0.29B | 0.30 |
| 2000-03-31 | $0.07B | $0.29B | 0.25 |
| 1999-12-31 | $0.08B | $0.28B | 0.27 |
| 1999-09-30 | $0.07B | $0.31B | 0.24 |
| 1999-06-30 | $0.08B | $0.33B | 0.24 |
| 1999-03-31 | $0.07B | $0.32B | 0.22 |
| 1998-12-31 | $0.08B | $0.31B | 0.27 |
| 1998-09-30 | $0.06B | $0.32B | 0.18 |
| 1998-06-30 | $0.07B | $0.31B | 0.23 |
| 1998-03-31 | $0.07B | $0.31B | 0.23 |
| 1997-12-31 | $0.07B | $0.30B | 0.25 |
| 1997-09-30 | $0.07B | $0.31B | 0.23 |
| 1997-06-30 | $0.06B | $0.32B | 0.17 |
| 1997-03-31 | $0.05B | $0.32B | 0.15 |
| 1996-12-31 | $0.05B | $0.32B | 0.16 |
| 1996-09-30 | $0.05B | $0.31B | 0.15 |
| 1996-06-30 | $0.05B | $0.30B | 0.17 |
| 1996-03-31 | $0.04B | $0.29B | 0.12 |
| 1995-12-31 | $0.03B | $0.28B | 0.12 |
| 1995-09-30 | $0.03B | $0.27B | 0.12 |
| 1995-06-30 | $0.03B | $0.11B | 0.30 |
| 1995-03-31 | $0.03B | $0.11B | 0.29 |
| 1994-12-31 | $0.02B | $0.10B | 0.22 |
| 1994-09-30 | $0.02B | $0.09B | 0.24 |
| 1994-06-30 | $0.02B | $0.09B | 0.25 |
| 1994-03-31 | $0.02B | $0.09B | 0.22 |
| 1993-12-31 | $0.01B | $0.08B | 0.17 |
| 1993-09-30 | $0.01B | $0.08B | 0.18 |
| 1993-06-30 | $0.01B | $0.08B | 0.16 |
| 1993-03-31 | $0.01B | $0.07B | 0.15 |
| 1992-12-31 | $0.01B | $0.07B | 0.14 |
| 1992-09-30 | $0.01B | $0.07B | 0.13 |
| 1992-06-30 | $0.01B | $0.07B | 0.15 |
| 1992-03-31 | $0.01B | $0.04B | 0.25 |
| 1991-12-31 | $0.01B | $0.03B | 0.21 |
| 1991-09-30 | $0.01B | $0.03B | 0.22 |
| 1991-06-30 | $0.01B | $0.03B | 0.24 |
| 1990-12-31 | $0.01B | $0.01B | 0.32 |
| 1990-09-30 | $0.01B | $0.03B | 0.24 |
| 1990-06-30 | $0.01B | $0.03B | 0.24 |
| 1989-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $56.979B | $3.898B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $220.924B | 26.25 |
| Intuitive Surgical (ISRG) | United States | $205.210B | 80.29 |
| Edwards Lifesciences (EW) | United States | $49.662B | 33.30 |
| Alcon (ALC) | Switzerland | $39.183B | 26.48 |
| IQVIA Holdings (IQV) | United States | $37.616B | 20.98 |
| Mettler-Toledo (MTD) | United States | $29.577B | 34.60 |
| STERIS (STE) | Ireland | $26.302B | 27.15 |
| DexCom (DXCM) | United States | $23.249B | 32.05 |
| Waters (WAT) | United States | $23.062B | 30.50 |
| Hologic (HOLX) | United States | $16.584B | 17.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.430B | 0.00 |
| Globus Medical (GMED) | United States | $11.441B | 23.80 |
| Penumbra (PEN) | United States | $10.977B | 77.21 |
| Masimo (MASI) | United States | $8.046B | 25.78 |
| Sysmex ADR (SSMXY) | Japan | $6.553B | 20.82 |
| Glaukos (GKOS) | United States | $5.319B | 0.00 |
| Teleflex (TFX) | United States | $4.927B | 7.85 |
| TransMedics (TMDX) | United States | $4.073B | 48.25 |
| Veracyte (VCYT) | United States | $3.344B | 38.11 |
| LivaNova (LIVN) | United Kingdom | $3.092B | 16.70 |
| Alphatec Holdings (ATEC) | United States | $3.082B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.436B | 11.43 |
| Artivion (AORT) | United States | $2.256B | 103.54 |
| Nihon Kohden (NHNKY) | Japan | $1.858B | 16.22 |
| Elekta AB (EKTAY) | Sweden | $1.739B | 16.85 |
| PROCEPT BioRobotics (PRCT) | United States | $1.719B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.240B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.225B | 0.00 |
| AxoGen (AXGN) | United States | $1.111B | 0.00 |
| IRadimed (IRMD) | United States | $1.099B | 52.38 |
| Pulse Biosciences (PLSE) | United States | $1.017B | 0.00 |
| OPKO Health (OPK) | United States | $1.013B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.942B | 5.10 |
| SiBone (SIBN) | United States | $0.781B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.604B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.549B | 31.93 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.546B | 10.89 |
| Pacific Biosciences Of California (PACB) | United States | $0.525B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.522B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.475B | 0.00 |
| NeuroPace (NPCE) | United States | $0.450B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.441B | 12.18 |
| OrthoPediatrics (KIDS) | United States | $0.426B | 0.00 |
| RxSight (RXST) | United States | $0.412B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.408B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.390B | 2.94 |
| Alpha Tau Medical (DRTS) | Israel | $0.337B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.303B | 50.53 |
| Spectral Diagnostics (EDTXF) | Canada | $0.298B | 0.00 |
| CVRx (CVRX) | United States | $0.250B | 0.00 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.212B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.183B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.149B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.148B | 0.00 |
| Neuronetics (STIM) | United States | $0.148B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.142B | 0.00 |
| Accuray (ARAY) | United States | $0.134B | 0.00 |
| LENSAR (LNSR) | United States | $0.124B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.075B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.025B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.51 |